Covid-19 can cause airway inflammation, lung damage, and breathing pattern abnormalities, which can raise the risk of sleep apnea. Modalert 200 mg, which contains modafinil, is prescribed to treat daytime drowsiness caused by narcolepsy, OSA, and shift work sleep disturbance. It increases brain neurotransmitters and wakefulness. However, individual circumstances and healthcare provider recommendations would determine its function in addressing COVID-19-related sleep apnea symptoms. Sleep difficulties following COVID-19 must be evaluated and treated by doctors.
Covid-19 can cause airway inflammation, lung damage, and breathing pattern abnormalities, which can raise the risk of sleep apnea. Modalert 200 mg, which contains modafinil, is prescribed to treat daytime drowsiness caused by narcolepsy, OSA, and shift work sleep disturbance. It increases brain neurotransmitters and wakefulness. However, individual circumstances and healthcare provider recommendations would determine its function in addressing COVID-19-related sleep apnea symptoms. Sleep difficulties following COVID-19 must be evaluated and treated by doctors.